A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells (Q40585082)

21 September 2017

A new modified DNA enzyme that targets influenza virus A mRNA inhibits viral infection in cultured cells (English)

1 reference

21 September 2017

Hitoshi Takahashi

1

1 reference

21 September 2017

Hiroyuki Hamazaki

2

1 reference

21 September 2017

Yuichiro Habu

3

1 reference

21 September 2017

Mieko Hayashi

4

1 reference

21 September 2017

Takayuki Abe

5

1 reference

21 September 2017

Naoko Miyano-Kurosaki

6

1 reference

21 September 2017

Hiroshi Takaku

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

21 September 2017

1 reference

21 September 2017

560

1 reference

21 September 2017

1-3

1 reference

21 September 2017

69-74

1 reference

A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Preclinical and clinical pharmacology of antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Antisense therapeutics: is it as simple as complementary base recognition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Synthetic oligonucleotides as therapeutics: the coming of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Is irrelevant cleavage the price of antisense efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Recent developments in the hammerhead ribozyme field

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

The hairpin ribozyme. Discovery, mechanism, and development for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Ribozyme gene therapy: applications for molecular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

A DNA enzyme that cleaves RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

A DNA enzyme with Mg(2+)-dependent RNA phosphoesterase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

A general purpose RNA-cleaving DNA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: inhibition of the coreceptor function by DNA-enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Facile preparation of nuclease resistant 3' modified oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Circular oligonucleotides: new concepts in oligonucleotide design

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

A novel method to stabilise antisense oligonucleotides against exonuclease degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Oligonucleotide N3'-->P5' phosphoramidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Mechanism and utility of an RNA-cleaving DNA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Emergence of influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Catalytic DNA: in training and seeking employment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900073-0

10.1016/S0014-5793(04)00073-0

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference